玻璃体内注射0.18毫克氟轻松醋酸酯植入剂治疗儿童葡萄膜炎
本回顾性队列研究纳入2020年6月1日至2023年3月1日期间接受0.18毫克玻璃体内氟轻松醋酸酯植入剂的18岁以下非感染性葡萄膜炎患者,共7例11眼。无复发率在6个月为82%、12个月为60%、24个月为60%;基线6只晶状体眼中2只随访期间需白内障摘除,植入前未行降眼压手术的4只眼中2只随访期间需手术。作者认为该植入剂对儿童葡萄膜炎(尤其睫状体扁平部炎)疗效与成人相似,但需干预的高眼压发生率更高。
要点
- 7例患儿11眼接受0.18毫克氟轻松醋酸酯植入剂,6例10眼为睫状体扁平部炎,1例1眼为免疫恢复性葡萄膜炎。
- 无复发率6个月82%、12个月60%、24个月60%。
- 基线6只晶状体眼中2只随访期间需白内障摘除;植入前未行降眼压手术的4只眼中2只随访期间需手术。
核心结论
- 0.18毫克氟轻松醋酸酯植入剂治疗儿童葡萄膜炎(尤其睫状体扁平部炎)的疗效与成人相似,但需干预的高眼压发生率更高。
研究设计与样本
- 回顾性队列研究,纳入2020年6月1日至2023年3月1日期间接受0.18毫克玻璃体内氟轻松醋酸酯植入剂的18岁以下患者,共7例11眼。
主要发现
- 7例中1例(1眼)诊断为免疫恢复性葡萄膜炎,其余6例(10眼)为睫状体扁平部炎。
- 无复发率6个月为82%、12个月为60%、24个月为60%。
- 基线6只晶状体眼中2只在随访期间需行白内障摘除。
- 植入前未行降眼压手术的4只眼中2只在随访期间需行手术。
关键数值与推荐
- 葡萄膜炎复发定义为炎症加重且需额外抗炎治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study reports the outcomes of the 0.18-mg intravitreal fluocinolone acetonide implant in the treatment of pediatric noninfectious uveitis. METHODS: A retrospective cohort study was performed on patients under 18 years old who received fluocinolone acetonide implant between June 1, 2020 and March 1, 2023. Data collected included demographics, uveitis diagnosis, use of anti-inflammatory therapy, visual acuity, intraocular pressure, and grading of uveitis activity. Uveitis recurrence was defined as increased inflammation that required additional anti-inflammatory therapy. RESULTS: Eleven eyes from seven patients were included in this study. One patient (one eye) had a diagnosis of immune recovery uveitis and the remaining six patients (10 eyes) had pars planitis. The rate of remaining recurrence-free was 82% at 6 months, 60% at 12 months, and 60% at 24 months. Two of the six phakic eyes at baseline required cataract extraction during follow-up. Two of the four eyes that did not have intraocular pressure-lowering surgery before implantation required surgery in follow-up. CONCLUSION: The 0.18-mg fluocinolone acetonide implant has a similar efficacy for the treatment of pediatric uveitis, particularly pars planitis, as in the adult population, although with higher rates of ocular hypertension requiring intervention.
引用
- Wangyu S, Jung JL, Pecen PE, et al. INTRAVITREAL 0.18-mg FLUOCINOLONE ACETONIDE IMPLANT FOR PEDIATRIC UVEITIS. Retina. 2024. PMID: 39287546. doi:10.1097/IAE.0000000000004179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。